期刊文献+

PS-341对肺动脉高压大鼠Nrf2/NF-κB表达的影响及作用机制

Effect of PS-341 on expression of Nrf2/NF-κB in rats with pulmonary arterial hypertension and its mechanism
原文传递
导出
摘要 目的探讨蛋白酶体抑制剂PS-341对高血流性肺动脉高压(PAH)大鼠肺血管内核因子E2相关因子2(Nrf2)、核因子-kappa B(NF-κB)活性的影响及其可能作用机制。方法将48只雌性Wistar大鼠随机分为生理盐水对照组、PS-341对照组、生理盐水分流组、PS-341治疗组。对照组行假手术,分流组行腹主动脉-下腔静脉造瘘术。术后3 d分别给予50μg/kg的PS-341或等体积的生理盐水,2次/周,共8周。测量血流动力学、肺形态学指标并进行HE染色;免疫组化、RT-PCR和Western blotting检测肺血管Nrf2、NF-κB-P65、Nqo1和MMP-2的表达水平。结果与对照组相比,分流组大鼠肺动脉管壁明显增厚、管腔狭窄,右心室平均收缩压(RVSP)、右心室肥厚指数(RVHI)及WT%、WA%增高(P均<0.05),且Nrf2、NF-κB、Nqo1及MMP-2表达增强(P<0.05)。PS-341干预后,与分流组相比,大鼠肺动脉管壁增厚及管腔狭窄程度明显减轻,RVSP、RVHI、WT%及WA%水平降低(P<0.05),NF-κB和MMP-2活性受抑制,而Nrf2和Nqo1表达明显增强(P<0.05)。结论 PS-341可能通过促进Nrf2基因及Nqo1的表达,同时抑制NF-κB及MMP-2的表达,延缓高肺血流性肺动脉高压的血管重构。 Objective To explore the effects and potential mechanism of PS-341 on nuclear factor E2-realated factor 2 ( Nrf2 ) and nuclear factor-kappa B (NF-KB) in remodeling vascular of rats with high-flow pulmonary arterial hyperten- sion (PAH). Methods Forty-eight female Wistar rats were randomly assigned to the vehicle/sham group, PS-341/ sham group, vehicle/shunt group, and PS-341-treated group. The model of aorto-caval shunting (ACS) was established by surgical methods to produce a high blood flow-induced pulmonary hypertension rats. The vehicle/sham and PS-341/ sham groups performed the sham operation. After operation for 3 days, the rats received an intraperitoneal injection of PS-341 (50 μg/kg · d) or vehicle for 8 weeks. The hemodynamic data and right ventricular injury were evaluated. The protein expressions of NF-KB, Nrf2, Nqol and MMP-2 were analyzed by immunohistochemisty and Western blotting. RT-PCR analysis was performed to detect the mRNA expression level of NF-KB. Results Compared with the vehicle/ sham group, the vehicle/shunt group had the higher levels of the right ventricular systolic pressure ( RVSP), right ven-tricular hypertrophy index ( RVHI), WT% and WA% ( P 〈 0.05 ), and the expressions of Nrf2, NF-KB-P65, Nqol and MMP-2 increased (P 〈 0.05 ). Compared with the vehicle/sham group, the PS-341-treated group deceased the lev- els of RVSP, RVHI, WT% and WA% ( P 〈 0.05 ), and the activation of NF-KB-P65 and MMP-2 were inhibited, but the expressions of Nrf2 and Nqol significantly increased (P 〈 0.05 ). Conclusion PS-341 might delay vascular re- modeling of high-flow PAH through promoting the expressions of Nrf2 and Nqol, and inhibiting the expressions of NF- KB and MMP-2.
出处 《山东大学学报(医学版)》 CAS 北大核心 2014年第2期6-11,共6页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金(ZR2011HM078)
关键词 肺动脉高压 PS-341 核因子E2相关因子2 核因子-kappa B 大鼠 Pulmonary arterial hypertension PS-341 Nuclear factor E2-realated factor 2 Nuclear factor-kappa B Rats
  • 相关文献

参考文献27

  • 1Park M H. Advabces in diagnosis and treatment in patients with pulmonary arterial hypertension[J].{H}Catheterization and Cardiovascular Interventions,2008,(2):205-213.
  • 2Miyata M F,Sakuma F,Yoshimura A. Pulmonary hypertension in rats.1.Role of bromodeoxyuridine-positive mononuclear cells and alveolar macrophages[J].{H}International Archives of Allergy and Immunology,1995,(3):281-286.
  • 3Hultg(a)dh-Nilsson A,L(o)vdahl C,Blomgren K. Expression of phenotype-and proliferation-related genes in rat aortic smooth muscle cells in primary culture[J].{H}Cardiovascular Research,1997,(2):418-430.
  • 4李晶,王军.电压依赖性钾离子通道在肺动脉高压发病过程中的作用[J].国际呼吸杂志,2011,31(3):238-240. 被引量:1
  • 5DeMarco V G,Habibi J,Whaley-Connell A T. Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat[J].{H}American Journal of Physiology Heart and Circulatory Physiology,2009,(3):H1128-H1139.
  • 6Jiang B H,Tardif J C,Sauvageau S. Beneficial effects of atorvastatin on lung structural remodeling and function in ischemic heart failure[J].{H}Journal of Cardiac failure,2010,(8):679-688.
  • 7Kobayashi A,Ohta T,Yamamoto M. Unique function of the nrf2-keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes[J].{H}Methods in Enzymology,2004.273-286.
  • 8Ho F M,Kang H C,Lee S T. The anti-inflammatory actions of lcy-2-cho,a carbazole analogue,in vascular smooth muscle cells[J].{H}Biochemical Pharmacology,2007,(2):298-308.
  • 9Liu G H,Qu J,Shen X. Nf-kappab/p65 antagonizes nrt2-are pathway by depriving cbp from nrf2 and facilitating recruitment of hdac3 to mafk[J].{H}Biochimica et Biophysica Acta,2008,(5):713-727.
  • 10Meiners S,Hocher B,Weller A. Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome[J].{H}HYPERTENSION,2004,(4):471-477.

二级参考文献23

  • 1McLaughlin VV, Archer SI., Badesch DB, et al. ACCF/ AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and lhe American Heart Association: developed in collaboration with the American College of Chest Physicians, An, erican Thoracic Society, Inc. , and the Pulmonary Hypertension Association. Circulation, 2009,119 : 2250 -2294.
  • 2Wang C, Wang J, Zhao L, et al. Sildenafil inhibits human puhnonary artery smooth muscle cell proliferation by decreasing capacitative Ca^2+ entry. J Pharmacol Sci, 2008,108:71-78.
  • 3Wang J, Weigand L, Wang W, et al. Chronic hypoxia inhibits Kv channel gene expression in rat distal pulmonary arlery. Am J Physiol Lung Cell Mol Physiol, 2005, 288, L1049 -L1058.
  • 4Pongs O, Kecskemethy N, Muller R,et al. Shaker encodes a family of putative potassium channel proteins in the nervous system of Drosophila. EMBO J,1988,7:1087-1096.
  • 5Weir EK, Olschewski A. Role of ion channels in acute and chronic responses of the pulmonary vasculalture to hypoxia. Cardiovasc Res,2006,71:630- 641.
  • 6Fantozzi I, Platoshyn O, Wong AH, et al. Bone morphogenetic protein 2 upregulates expression and function of voltage gated K^- channels in human pulmonary artery smooth muscle cells. Am J Physiol,2006,291:L993-L1004.
  • 7Archer SL. Wu XC, Thdbaud B. et al. Preferential expression and function of voltage-gated, O2 sensitive K^+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. CircRes,2004,95:308-318.
  • 8Archer SI. distribution conduit and nitric oxide Huang jM, Reeve HL, et al. Differential of electrophysiologically distinct myocytes in resistance arteries determines their response to and hypoxia. Circ Rre,1996,78:431-442.
  • 9Platoshyn O,Yu Y, No EA,et al. Heterogeneity of hypoxiamedialed decrease in I(K(V)) and increase in [Ca^2+](cyt) in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol, 2007,293: L402 -L416.
  • 10Ekhterae D, Platoshyn O, Krick S, et al. Bcl-2 decreases voltage gated K^+ channel activity and enhances survival in vascular srnooth muscle cells. Am J Physiol Physiol, 2001, 281 :C157 -C165.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部